Alpharx Inc is related to 1 other symbol. To date we've encountered 7 releases involving Alpharx Inc.
Last Price: 0.05 (0.00) - 12/1/2008,
9:30am
A "business partner" is defined as a third party company that has co-released at least one press release with Alpharx Inc.
HONG KONG (MARKET WIRE) AlphaRx International Holdings Limited ("AIH"), subsidiary of AlphaRx Inc. (OTCBB: ALRX), announces that they are entering into the multi billion dollars oncology market with two nanotechnology based products, to address hepatic and lung cancer respectively.
MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTCBB: ALRX) announces that the Company has filed a second patent application with the U.S. Patent and Trademark Patent Office for its nanoparticle-based drug delivery platform covering several antibiotic products being developed by the Company targeted to treat life threatening infectious diseases.
MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTCBB: ALRX) is pleased to announce the appointment of Michael S. Berlin, M.D., M.S., dedicated to advancing and improving the care of patients with eye diseases, to its Scientific Advisory Board.
MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTCBB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application entitled "Stabilization of Benzoyl Peroxide in Solution."
TORONTO (MARKET WIRE) Anti Aging Medical Group Corp. (PINKSHEETS: AAGM), a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits, announces the North American marketing rights for their brand new product, CoQ10 ER a dietary supplement created to protect against age-related degeneration. The
MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTC BB: ALRX), an emerging biopharmaceutical company, announced today that it has entered into a collaboration with PharmaSeed Ltd. of Israel, a bio-pharmaceutical company specializing in drug discovery and early development phases for the development of new drugs for the potential treatment of CNS disorders such as stroke and multiple sclerosis.
MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTC BB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, announced today that its wholly owned subsidiary, AlphaRx International Holdings Limited ("AIH"), has entered into a Joint Venture Agreement, ("JV") with a leading Chinese marketing company (the "China Party"), to establish a Joint Venture Company ("JV
For more information, please contact: Agora Investor Relations Corp. Web: http://www.agoracom.com E-mail: Email Contact
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.